Pharma channel feed

Take­da bets $100M up­front on AC Im­mune's an­ti-amy­loid Alzheimer's vac­cine

Last year
Deals

Sanofi buys ex-US rights to Ful­crum's Phase 3 rare neu­ro­mus­cu­lar drug

Last year
Deals

New Biose­cure draft fea­tures 2032 grand­fa­ther clause, five-year grace pe­ri­od for added com­pa­nies

Last year
China
FDA+

Sen­a­tors ques­tion Cham­ber of Com­merce's mo­tives around march-in rights

Last year
FDA+

House Re­pub­li­cans put pres­sure on AS­PR’s man­age­ment of the na­tion­al drug stock­pile

Last year
Law

FDA de­lays Mod­er­na RSV vac­cine de­ci­sion, but what's next is like­ly to be a tougher, longer climb

Last year

Sanofi grabs a share of No­vavax's Covid vac­cine for $500M, eye­ing com­mer­cial­iza­tion, flu com­bi­na­tion

Last year
Deals
Coronavirus

Af­ter FTC scruti­ny of Sanofi deal, Maze finds a new Pompe part­ner in Sh­iono­gi

Last year
Deals
R&D

Take­da to shut down San Diego re­search cen­ter 

Last year
People

Ahead of like­ly ap­proval, ICER finds Geron’s ime­tel­stat is not cost-ef­fec­tive at $250,000 an­nu­al­ly

Last year
FDA+

Blue­bird bio starts 15 pa­tients on its three mul­ti­mil­lion-dol­lar gene ther­a­pies

Last year
Cell/Gene Tx

Up­dat­ed: Take­da to re­vamp in mul­ti­year quest, piv­ots CAR-NK ther­a­py from can­cer to au­toim­mune

Last year

House pan­el marks up bill to re­quire PBMs to use a flat fee in Medicare

Last year
FDA+

In­side CVS Care­mark’s move that broke Hu­mi­ra’s hold on the mar­ket

Last year
Health Tech

Te­va to close ad­di­tion­al man­u­fac­tur­ing sites as it en­ters next phase of 'piv­ot to growth'

Last year
Manufacturing

As­traZeneca pulls Covid-19 vac­cine glob­al­ly as the phar­ma sees 'no fu­ture com­mer­cial de­mand'

Last year
R&D
Coronavirus

Pa­tient dies in Pfiz­er’s Phase 2 Duchenne mus­cu­lar dy­s­tro­phy tri­al

Last year

White House un­veils long-await­ed pol­i­cy on over­see­ing re­search of con­cern

Last year
FDA+

Madri­gal 'en­cour­aged' by ear­ly launch progress of land­mark NASH drug

Last year

Ver­tex touts Cas­gevy sick­le cell launch as blue­bird makes progress with ri­val Lyf­ge­nia

Last year
Cell/Gene Tx

Sen. Cas­sidy calls on Biden to do bet­ter at shar­ing H5N1 bird flu in­for­ma­tion

Last year
FDA+

In­dus­try groups cri­tique new guid­ance for Medicare drug price ne­go­ti­a­tions in 2027

Last year
FDA+

As­traZeneca ex­pands stake in cell and gene ther­a­py part­ner Cel­lec­tis

Last year
Financing
Cell/Gene Tx

Pfiz­er hires Citi an­a­lyst Baum to over­see port­fo­lio strat­e­gy

Last year
People
First page Previous page 56575859606162 Next page Last page
A service from the Financial Times